Johnson & Johnson's single-shot Janssen COVID-19 vaccine gets FDA EUA

As anticipated, Johnson & Johnson has received an Emergency Use Authorization (EUA) from the FDA for its single-shot Janssen COVID-19 vaccine. With this authorization in place, Johnson & Johnson’s product is the third COVID-19 vaccine to be distributed in the United States, one that can be stored in a refrigerator, which reduces the logistical burden. Unlike the Pfizer and Moderna …